The Lost Decade: A 2025 Scoping Review Maps Why OCD Goes Untreated for 12 Years
- Across the pooled samples synthesised in this 2025 review, the mean gap from first OCD symptoms to a correct diagnosis was 12.78 years, with a further 1.45 years between diagnosis and the start of adequate therapy.
- One cohort placed OCD's treatment gap at 84 percent, the second highest of all the disorders compared, meaning the large majority of people who needed care were not receiving it.
- The review screened 8135 records and extracted data from 51 studies, organising the drivers of delay into recognisable themes: misunderstanding of OCD, stigma, logistical and cost barriers, and the symptom content itself.
- Symptom type shifted the delay: people with taboo obsessions, such as aggressive, sexual, or religious intrusions, waited longer for care, and in some samples consulted traditional or religious helpers before any psychiatric advice.
This is not a new clinical trial. It is a map of a system failure, and for a slot built around the rigid, compulsive brain it answers a question the neuroscience cannot: if effective treatment for obsessive-compulsive disorder has existed for thirty years, why does the average patient lose more than a decade before reaching it?
The headline figure deserves to be read slowly. A mean of 12.78 years from symptom onset to diagnosis is not a queue or a waiting list; it is a person living through their late teens and twenties – the formative years for education, partnership, and career – without ever being told what is wrong with them. The additional 1.45 years from diagnosis to adequate therapy is almost a footnote by comparison, but it confirms that the bottleneck is not only access to treatment. It is recognition. The disorder is hiding in plain sight, often inside the patient's own silence.
Why the delay is structural, not accidental
The review's value is that it refuses to blame a single villain. It groups the evidence into themes, and each theme is a different point of failure. Misunderstanding of OCD means symptoms are misread as personality, as faith, or as ordinary worry. Stigma keeps the most distressing intrusions – the aggressive, sexual, and blasphemous thoughts that are diagnostically typical – precisely the ones patients are least willing to disclose. Logistical and cost barriers then filter out those who do seek help. The result is a sieve with four layers, and a patient must pass through all of them before exposure and response prevention is even on the table.
What the 84 percent figure tells a clinician
A treatment gap of 84 percent in one of the analysed cohorts, higher than the gaps reported for several other conditions, reframes OCD as an access problem rather than a treatment problem. The interventions work; the pipeline leaks. For practitioners this carries a concrete implication. The patients most likely to be lost are not the visible washers and checkers but those whose obsessions are shameful enough to stay unspoken. Screening that asks directly and non-judgementally about intrusive thoughts – rather than waiting for the patient to volunteer them – is the single cheapest correction this evidence points to.
When the average distance between a treatable symptom and its diagnosis is measured in years rather than weeks, the clinical failure is one of recognition, not of remedy.
This is a scoping review, not a meta-analysis, so the headline durations are pooled estimates from heterogeneous samples rather than a single weighted figure. The literature search closed in mid-2023, and the review excluded non-English studies, which may understate delays in regions where stigma and traditional healing are most prominent. Treatment-gap and duration figures come from different cohorts and should not be read as a single national statistic.